Surgical guidelines for the management of breast cancer

European Journal of Surgical Oncology

Volumn 35, Issue SUPPL. 1, 2009, Pages 1-22

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; EXEMESTANE; GESTAGEN; GONADORELIN; LETROZOLE; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; AXILLARY LYMPH NODE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURGERY; CARDIOTOXICITY; FOLLOW UP; FROZEN SECTION; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH SERVICE; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; LOBULAR IN SITU NEOPLASIA; MASTECTOMY; METASTASIS; NEOPLASM; OVARIECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THORAX WALL; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 63449133617     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.11.001     Document Type: Editorial

References (51)

1. Quality assurance guidelines for surgeons in breast cancer screening. NHSBSP Publication No. 20; 1992.
2. The Breast Surgeons Group of the British Association of Surgical Oncology. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom. Eur J Surg Oncol 21 Suppl. A (1995) 1-13
3. A policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales (1995), HMSO, London
4. The NHS cancer plan - a plan for investment, a plan for reform (2000), Department of Health, London
5. NICE. Improving outcomes in breast cancer - manual update (2002), National Institute for Clinical Excellence, London
6. Cancer Reform Strategy (2007), Department of Health, London
7. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of randomized trials. Lancet 366 (2005) 2087-2106
8. Sainsbury R., Haward B., Rider L., et al. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345 8960 (1995) 1265-1270
9. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 18 11 (2000) 2327-2340
10. Gillis C.R., and Hole D.J. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the West of Scotland. BMJ 312 7024 (1996) 145-148
11. Bishop H.M., Blamey R.W., Morris A.H., et al. Bone scanning: its lack of value in the follow up of patients with breast cancer. Br J Surg 66 10 (1979) 752-754
12. The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271 20 (1994) 1587-1592
13. Khatcheressian J.L., Wolff A.C., Smith T.J., et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guideline in the adjuvant setting. J Clin Oncol 24 31 (2006) 5091-5097
14. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 16 (2002) 1233-1241
15. Veronesi U., Saccozzi R., Vecchio D., et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305 1 (1981) 6-11
16. Arriagada R., Le M.G., Rochard F., et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up. J Clin Oncol 14 (1996) 1558
17. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 5 (1985) 979-990
18. van Dongen J.A., Bartelink H., Fentiman I.S., et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer (1992) 801-805
19. Dewar J.A., Haviland J.S., Agrawal R.K., et al. Hypofractionation for early breast cancer: first results of the UK standardisation of breast radiotherapy (START) trials. J Clin Oncol 25 18S (2007) LBA518
20. Forrest A.P., Everington D., McDonald C.C., et al. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 82 11 (1995) 1504-1508
21. Fowble B., Solin L.J., Schultz D.J., et al. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17 4 (1989) 703-710
22. Siegel B.M., Mayzel K.A., and Love S.M. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 125 9 (1990) 1144-1147
23. Halverson K.J., Taylor M.E., Perez C.A., et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 26 4 (1993) 593-599
24. Chetty U., Jack W., Prescott R.J., et al. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg 87 2 (2000) 163-169
25. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98 9 (2006) 599-609
26. Silverstein M.J., Lagios M.D., Craig P.H., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 77 11 (1996) 2267-2274
27. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 21 (2006) 3381-3387
28. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8 1 (1990) 113-118
29. Salvadori B., Bartoli C., Zurrida S., et al. Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer 27 1 (1991) 35-37
30. Bodian C.A., Perzin K.H., and Lattes R. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer 78 5 (1996) 1024-1034
31. Rosen P.P., Kosloff C., Lieberman P.H., et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2 3 (1978) 225-251
32. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 78 7 (1996) 1403-1416
33. Association of Breast Surgery at BASO, the British Association of Plastic, Reconstructive and Aesthetic Surgeons and the Training Interface Group in Breast Surgery. Oncoplastic breast surgery - a guide to good practice. Eur J Surg Oncol 33 (2007) S1-S23
34. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 14 (1997) 949-955
35. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 9165 (1999) 1641-1648
36. Holmberg L., Garmo H., Granstrand B., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26 8 (2008) 1247-1252
37. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362 9378 (2003) 95-102
38. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 4 (2001) 400-418
39. Viani G.A., Stefano E.J., Afonso S.L., et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2 (2007) 28
40. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 9472 (2005) 1687-1717
41. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 16 (2005) 1673-1684
42. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 16 (2005) 1659-1672
43. NICE technology appraisal guidance 107. Trastuzumab for the adjuvant treatment of early-stage HER2 positive breast cancer.
44. Joseph E., Hyacinthe M., Lyman G.H., et al. Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 5 6 (1998) 522-528
45. Wheeler T., Stenning S., Negus S., et al. Evidence to support a change in follow-up policy for patients with breast cancer: time to first relapse and hazard rate analysis. Clin Oncol 11 3 (1999) 169-173
46. Ciatto S. Detection of breast cancer local recurrences. Ann Oncol 6 Suppl. 2 (1995) 23-26
47. Gulliford T., Opomu M., Wilson E., et al. Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ 314 7075 (1997) 174-177
48. Rosselli Del Turco M., Palli D., Cariddi A., et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271 20 (1994) 1593-1597
49. Harries S.A., Lawrence R.L., Scrivener R., et al. The investigation and treatment of breast cancer in England and Wales. Ann R Coll Surg Engl 78 (1996) 197-202
50. Guidance on screening and symptomatic imaging. 2nd ed. (2003), The Royal College of Radiologists, London
51. The use of imaging in the follow-up of patients with breast cancer (1995), The Royal College of Radiologists, London